Henry Schein
HSIC
83.66
-1.18
-1.39%
Henry Schein
US · HSIC
#1526 by market cap
Listed 1970
83.66
-1.18
-1.39%
Live - 5344 symbols - heartbeat 548s ago
· 2026-10-08 07:27
Pre-market
81.56
-2.51%
After-hours
83.66
0.00%
- Market cap
- 9.32B
- P/E (TTM)i
- 24.39
- P/Bi
- 2.95
- EPSi
- 3.27
- Div yieldi
- 0.00%
- 52W posi
- 72%
Reader sentiment
Are you bullish or bearish on HSIC?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Accumulating
- The number of reporting institutions decreased by 2 in the most recent period (2026/Q3).
- Total institutional ownership rose 0.4 percentage points.
Institutional ownership
- Held by institutions
- 114.88% +0.37pp
- Institutions
- 667 -2
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund78.36%
VC/PE Fund14.71%
Hedge Fund11.09%
Public Company4.60%
Private Company3.35%
Individual/Insider1.19%
Sovereign Wealth Fund1.12%
Government Pension Fund0.99%
Insurance Company0.37%
Top holders as of 2026-06-30
KKR & Co. Inc.
14.04% · 15.65M sh
BlackRock
6.30% · 7.02M sh
Vanguard Capital Management, LLC
6.18% · 6.89M sh
FMR
6.09% · 6.79M sh
Artisan Partners Limited Partnership
5.80% · 6.47M sh
State Street Global Advisors
3.86% · 4.31M sh
Vanguard Portfolio Management, LLC
3.71% · 4.13M sh
J.P. Morgan Asset Management, Inc.
3.39% · 3.77M sh
American Century Investment Management
3.10% · 3.46M sh
Dimensional Fund Advisors
3.05% · 3.39M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 25 buys · 22 sells
| Name | Role | Stake |
|---|---|---|
| KKR & Co. Inc. | -- | 14.04% |
| Stanley Bergman | Executive Chairperson | 0.58% |
| James Breslawski | Executive Vice Chairman & President | 0.14% |
| Andrea Albertini | Chief Executive Officer of International Distribution Group | 0.10% |
| Tom Popeck | Chief Executive Officer of Healthcare Specialties Group | 0.08% |
| Bradford Connett | Chief Executive Officer of North America Distribution Group | 0.06% |
| Walter Siegel | Chief Legal Officer | 0.04% |
| Carol Raphael | Independent Director | 0.03% |
| Joseph Herring | Independent Director | 0.02% |
| Michael Ettinger | Chief Operating Officer | 0.02% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-07 | Andrea Albertini | Chief Executive Officer of International Distribution Group | Sale to Issuer | -4,587 | $88.86 |
| 2026-06-29 | Joseph Herring | Independent Director | Intent to Sell (Form 144) | -28,791 | $84.29 |
| 2026-06-11 | William Daniel | Independent Director | Other Acquisition | +2,215 | -- |
| 2026-05-25 | Stanley Bergman | Executive Chairperson | Other Disposition | -50 | -- |
| 2026-05-20 | Kelly Murphy | General Counsel | Initial Statement of Beneficial | 0 | -- |
| 2026-05-18 | Stanley Bergman | Executive Chairperson | Other Disposition | -1,040 | -- |
| 2026-05-10 | William Daniel | Independent Director | Open Market Acquisition | +10,000 | $69.19 |
| 2026-03-18 | Tom Popeck | Chief Executive Officer of Healthcare Specialties Group | Open Market Disposition | -1,355 | $72.79 |
| 2026-03-16 | Michael Ettinger | Chief Operating Officer | Other Disposition | -2,300 | -- |
| 2026-03-15 | Stanley Bergman | Executive Chairperson | Sale to Issuer | -50 | $74.61 |
| 2026-03-15 | Stanley Bergman | Executive Chairperson | Other Disposition | -400 | -- |
| 2026-03-15 | Mark Mlotek | Executive VP, Chief Strategic Officer & Executive Director | Sale to Issuer | -5,928 | $74.61 |
| 2026-03-15 | Michael Ettinger | Chief Operating Officer | Sale to Issuer | -4,214 | $74.61 |
| 2026-03-15 | Ronald South | Senior Vice President | Sale to Issuer | -5,216 | $74.61 |
| 2026-03-15 | Andrea Albertini | Chief Executive Officer of International Distribution Group | Sale to Issuer | -1,401 | $74.61 |
| 2026-03-15 | Tom Popeck | Chief Executive Officer of Healthcare Specialties Group | Sale to Issuer | -587 | $74.61 |
| 2026-03-15 | Christine Sheehy | Chief Human Resources Officer | Sale to Issuer | -463 | $74.61 |
| 2026-03-11 | Stanley Bergman | Executive Chairperson | Other Disposition | -970 | -- |
| 2026-03-09 | Kurt Kuehn | Independent Director | Open Market Disposition | -2,844 | $78.96 |
| 2026-03-05 | Henry Kravis | -- | Other Derivative Acquisition | +918,723 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 07:27:26 · For reference only, not investment advice and not tailored to your situation.